Treatments
Featured Article
Treating Acute Urinary Tract Infection in Postmenopausal Women
Expert perspective on management and treatment of acute urinary tract infections in postmenopausal women.
Latest News
Is Short-Course Antibiotic Treatment for CAP Effective?
To investigate what impact antibiotic treatment duration has on CAP outcomes, researchers from the Warren Alpert Medical School of Brown University conducted a search of various databases for studies comparing the safety and efficacy of treatment regimens lasting ≤6 days (short) and ≥7 days (long).
FDA Strengthens Warnings for Fluoroquinolone Antibiotics
The labeling changes are based on a review of postmarketing adverse event reports found in the FDA Adverse Event Reporting System (FAERS) database and published medical literature.
FDA Approves Plazomicin for Complicated Urinary Tract Infections
Zemdri carries a Boxed Warning describing reports of nephrotoxicity, ototoxicity, and neuromuscular blockade, as well as fetal harm if administered during pregnancy.
Potential Significant Toxicity With Methotrexate, Trimethoprim-Sulfamethoxazole Combination
The case involved a 68-year-old female patient with rheumatoid arthritis on methotrexate 10mg weekly who presented to the emergency department with complaints of lethargy and weakness after being prescribed a 2-week course of TS for a bacterial skin infection.
FDA Approves New Treatment for Onchocerciasis
Moxidectin, a macrocyclic lactone, is an anthelmintic drug that selectively binds to the parasite's glutamate-gated chloride ion channels.
FDA Grant Orphan Drug Status to Brincidofovir for Smallpox
Brincidofovir is the Company's lead candidate, a nucleotide analog that has antiviral activity against variola virus, which causes smallpox.
Treatment for Prosthetic Joint Infections Gets FDA's QIDP Designation
PJI is a challenging complication of joint arthroplasty with few effective treatment options.
Children Typically Have 14 Simple Infections by Age 3 Years
Children experience a median of 14 infections during their first three years of life, though there is large variation in incidence.
First Single-Dose Oral Therapy for Bacterial Vaginosis Launched
In both pivotal trials, a statistically significant greater percentage of treatment patients experienced clinical response vs those treated with placebo at 21 to 30 days following a single dose.
Infection Risk With Second-Generation Disease-Modifying Treatments in MS
Investigators examined the association between infection-related medical encounters and disease-modifying treatments for multiple sclerosis.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Improving the Care of Aging Adults Living With HIV
- Infection Prevention Differs Between Small, Large Hospitals
- International Antiviral Society-USA Updates Recommendations for HIV Treatment and Prevention
- FDA Warns Against Long-Term Azithromycin Use for Some
- Previous Missed Appointments Predict Likelihood of Trend in Patients With HIV
- Antibiotics Often Unnecessary for Sacral Pressure Ulcers Complicated by Osteomyelitis
- Identifying the Source of C difficile in Hospitalized Patients
- International Antiviral Society-USA Updates Recommendations for HIV Treatment and Prevention
- Sensitivity and Specificity of 7 Treponemal Tests for Syphilis Diagnosis
- Automated EHR Algorithm More Effective Than Nurse-Driven Protocol for HCV, HIV Screening
- HCV Eradication in HIV/HCV-Coinfection Decreases Immune Activation
- Tolerability of Switching to Long-acting Cabotegravir Plus Rilpivirine From Current HIV-1 Regimen
- Time to Blood Culture Positivity Predictive of Mortality in S Aureus Infective Endocarditis
- C difficile Tied to Increased Graft Loss in Solid Organ Recipients
- Neurodevelopmental Anomalies, Birth Defects Linked to Zika ID'd
